Monday morning was a dull one at Wave Life Sciences (NASDAQ:WVE). This was because the company’s shares declined by 50%. About the flop Analysts attribute this major drop to the recent discontinuation of the company’s suvodirsen. It was a product under development to help patients struggling with a condition known as Duchenne muscular dystrophy. DMD […]
Sign Up To Get Our Instant Alerts!
- Japanese Premier Declares COVID-19 State of Emergency in Tokyo 52 views
- Toyota Suspends Production at 2 Plants in Japan Citing Chip Shortage 52 views
- Expect Even More Unique Electric Cars Says Ferrari 44 views
- Kimberly Goldwin Poised to Become Next President of ABC News 31 views
- Records Show 19,000 U.S Based Amazon Employees Contracted Coronavirus 28 views